STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Montanaro Asset Management Limited, London, UK, has notified us pursuant to
sec. 21 para. 1 WpHG on 10 December 2013, that on 5 December 2013 the share
of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went below the threshold of 5% and that the percentage of
voting rights on that day amounted to 4.78% (562,565 voting rights).
Montanaro Asset Management Limited has notified us that these voting rights
of 4.78% (562,565 voting rights) are attributable to Montanaro European
Smaller Companies PLC pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG.
13.12.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Company: STRATEC Biomedical AG
End of Announcement DGAP News-Service